Bonum Therapeutics, Inc.
Industry: Biotechnology (See others in industry)
Address:
1150 Eastlake Avenue E Suite 1100
Seattle, WA, 98109
Phone: 206-888-8485
Seattle, WA, 98109
Phone: 206-888-8485
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-17 | New | $26,907,396 | $26,907,396 | Equity Only | 06b | SEC link |
| 2022-11-29 | New | $45,041,421 | $45,041,421 | Equity Only | 06b | SEC link |
| 2021-12-22 | New | $1,186,887 | $1,186,887 | Equity Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Gaurav Aggarwal | Director |
| Samuel Bjork | Director |
| Samuel Blackman | Director |
| Karl Handelsman | Director |
| Diane Hollenbaugh | Executive |
| John Mc Kearn | Director |
| John Mulligan | Director, Executive, Promoter |
| Mitchell Mutz | Director |
| Neela Patel | Executive |
| Monique Schiersing | Director |
| Nicholas Walrod | Director |